Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung

BACKGROUND: Uncontrolled inflammation is a central problem for many respiratory diseases. The development of potent, targeted anti-inflammatory therapies to reduce lung inflammation and re-establish the homeostasis in the respiratory tract is still a challenge. Previously, we developed a unique anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lu, Rao, Yafei, Liu, Xiali, Sun, Liya, Gong, Jiameng, Zhang, Huasheng, Shen, Lei, Bao, Aihua, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905431/
https://www.ncbi.nlm.nih.gov/pubmed/33632244
http://dx.doi.org/10.1186/s12951-021-00803-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905431/
https://www.ncbi.nlm.nih.gov/pubmed/33632244
http://dx.doi.org/10.1186/s12951-021-00803-w

Ejemplares similares